173 related articles for article (PubMed ID: 24991188)
21. Major histocompatibility complex and strong human leukocyte antigen-DRB1 and gender association with Vogt-Koyanagi-Harada syndrome in Mexican Mestizos.
Aláez C; Flores-A H; Concha del Río LE; Munguía A; Rodríguez A; García D; Arellanes L; Gorodezky C
Hum Immunol; 2011 Dec; 72(12):1198-203. PubMed ID: 21964432
[TBL] [Abstract][Full Text] [Related]
22. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982
[TBL] [Abstract][Full Text] [Related]
24. Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma.
Crosson JN; Laird PW; Debiec M; Bergstrom CS; Lawson DH; Yeh S
J Immunother; 2015; 38(2):80-4. PubMed ID: 25658618
[TBL] [Abstract][Full Text] [Related]
25. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
26. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
[TBL] [Abstract][Full Text] [Related]
27. Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease.
Kogiso M; Tanouchi Y; Miki S; Mimura Y
Jpn J Ophthalmol; 1992; 36(1):37-43. PubMed ID: 1635294
[TBL] [Abstract][Full Text] [Related]
28. HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.
Iqniebi A; Gaafar A; Sheereen A; Al-Suliman A; Mohamed G; Al-Hussein K; Tabbara KF
Mol Vis; 2009 Sep; 15():1876-80. PubMed ID: 19756183
[TBL] [Abstract][Full Text] [Related]
29. Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2D
Bonacini M; Cimino L; De Simone L; Bolletta E; Gozzi F; Soriano A; Muratore F; Zerbini A; Fontana L; Salvarani C; Croci S
Clin Exp Immunol; 2021 Apr; 204(1):41-48. PubMed ID: 33314028
[TBL] [Abstract][Full Text] [Related]
30. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
Robbins PF; El-Gamil M; Li YF; Zeng G; Dudley M; Rosenberg SA
J Immunol; 2002 Nov; 169(10):6036-47. PubMed ID: 12421991
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 expression by CD4 T lymphocytes in Vogt-Koyanagi-Harada disease.
Ohta K; Yoshimura N
Ocul Immunol Inflamm; 2002 Jun; 10(2):93-103. PubMed ID: 12778345
[TBL] [Abstract][Full Text] [Related]
32. Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome.
Kahn M; Pepose JS; Green WR; Miller J; Foos RY
Ophthalmology; 1993 Aug; 100(8):1191-8. PubMed ID: 8341501
[TBL] [Abstract][Full Text] [Related]
33. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease.
Yi S; Chang R; Hu J; Qiu Y; Wang Q; Cao Q; Yuan G; Su G; Zhou C; Wang Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4662-4669. PubMed ID: 30267088
[TBL] [Abstract][Full Text] [Related]
34. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
Yi X; Yang P; Sun M; Yang Y; Li F
Mol Vis; 2011 Mar; 17():673-9. PubMed ID: 21403851
[TBL] [Abstract][Full Text] [Related]
35. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease.
Imai Y; Sugita M; Nakamura S; Toriyama S; Ohno S
Curr Eye Res; 2001 Apr; 22(4):312-8. PubMed ID: 11462171
[TBL] [Abstract][Full Text] [Related]
36. Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: a systematic review and meta-analysis.
Shi T; Lv W; Zhang L; Chen J; Chen H
Sci Rep; 2014 Nov; 4():6887. PubMed ID: 25382027
[TBL] [Abstract][Full Text] [Related]
37. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.
Ventura C; Bisceglia H; Girerd-Chambaz Y; Burdin N; Chaux P
J Clin Immunol; 2012 Dec; 32(6):1305-16. PubMed ID: 22797815
[TBL] [Abstract][Full Text] [Related]
39. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats.
Yamaki K; Kondo I; Nakamura H; Miyano M; Konno S; Sakuragi S
Exp Eye Res; 2000 Oct; 71(4):361-9. PubMed ID: 10995557
[TBL] [Abstract][Full Text] [Related]
40. Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
Correale J; Rojany M; Weiner LP
J Neuroimmunol; 1997 Dec; 80(1-2):47-64. PubMed ID: 9413259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
